Histone demethylase JMJD5 is essential for embryonic development

Biochemical and Biophysical Research Communications

Volumn 420, Issue 1, 2012, Pages 61-65

  Oh, Sangphil ^a   Janknecht, Ralf ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Embryonic development; Gene knockout; Histone demethylase; JMJD5; P21; P53

Indexed keywords

HISTONE DEMETHYLASE; JUMONJI C DOMAIN CONTAINING 5 ENZYME; PROTEIN NOXA; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL CYCLE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; GENE SILENCING; GENOTYPE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; UPREGULATION; YOLK SAC;

ANIMALS; BREAST NEOPLASMS; DOWN-REGULATION; EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; FEMALE; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; LEUKEMIA; MICE; MICE, KNOCKOUT; ONCOGENE PROTEINS; UP-REGULATION;

MUS;

EID: 84859099457     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.02.115     Document Type: Article

References (26)

1. Cloos P.A., Christensen J., Agger K., Helin K. Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes Dev. 2008, 22:1115-1140.
2. Chi P., Allis C.D., Wang G.G. Covalent histone modifications - miswritten, misinterpreted and mis-erased in human cancers. Nat. Rev. Cancer 2010, 10:457-469.
3. Spannhoff A., Hauser A.T., Heinke R., Sippl W., Jung M. The emerging therapeutic potential of histone methyltransferase and demethylase inhibitors. ChemMedChem 2009, 4:1568-1582.
4. Klose R.J., Zhang Y. Regulation of histone methylation by demethylimination and demethylation. Nat. Rev. Mol. Cell Biol. 2007, 8:307-318.
5. Shi Y., Whetstine J.R. Dynamic regulation of histone lysine methylation by demethylases. Mol. Cell 2007, 25:1-14.
6. Hsia D.A., Tepper C.G., Pochampalli M.R., Hsia E.Y., Izumiya C., Huerta S.B., Wright M.E., Chen H.W., Kung H.J., Izumiya Y. KDM8, a H3K36me2 histone demethylase that acts in the cyclin A1 coding region to regulate cancer cell proliferation. Proc. Natl. Acad. Sci. USA 2010, 107:9671-9676.
7. Wagner E.J., Carpenter P.B. Understanding the language of Lys36 methylation at histone H3. Nat. Rev. Mol. Cell Biol. 2012, 13:115-126.
8. Jones M.A., Covington M.F., DiTacchio L., Vollmers C., Panda S., Harmer S.L. Jumonji domain protein JMJD5 functions in both the plant and human circadian systems. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:21623-21628.
9. Jones M.A., Harmer S. JMJD5 Functions in concert with TOC1 in the Arabidopsis circadian system. Plant Signaling Behav. 2011, 6:445-448.
10. Shin S., Rossow K.L., Grande J.P., Janknecht R. Involvement of RNA helicases p68 and p72 in colon cancer. Cancer Res. 2007, 67:7572-7578.
11. Shin S., Kim T.D., Jin F., van Deursen J.M., Dehm S.M., Tindall D.J., Grande J.P., Munz J.M., Vasmatzis G., Janknecht R. Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81. Cancer Res. 2009, 69:8102-8110.
12. Goueli B.S., Janknecht R. Regulation of telomerase reverse transcriptase gene activity by upstream stimulatory factor. Oncogene 2003, 22:8042-8047.
13. Kim J., Shin S., Subramaniam M., Bruinsma E., Kim T.D., Hawse J.R., Spelsberg T.C., Janknecht R. Histone demethylase JARID1B/KDM5B is a corepressor of TIEG1/KLF10. Biochem. Biophys. Res. Commun. 2010, 401:412-416.
14. Goel A., Janknecht R. Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu. Mol. Cell. Biol. 2003, 23:6243-6254.
15. Mooney S.M., Goel A., D'Assoro A.B., Salisbury J.L., Janknecht R. Pleiotropic effects of p300-mediated acetylation on p68 and p72 RNA helicase. J. Biol. Chem. 2010, 285:30443-30452.
16. Papoutsopoulou S., Janknecht R. Phosphorylation of ETS transcription factor ER81 in a complex with its coactivators CREB-binding protein and p300. Mol. Cell. Biol. 2000, 20:7300-7310.
17. Kim T.D., Shin S., Janknecht R. Repression of Smad3 activity by histone demethylase SMCX/JARID1C. Biochem. Biophys. Res. Commun. 2008, 366:563-567.
18. Ishimura A., Minehata K., Terashima M., Kondoh G., Hara T., Suzuki T. Jmjd5, an H3K36me2 histone demethylase, modulates embryonic cell proliferation through the regulation of Cdkn1a expression. Development (Cambridge, U. K.) 2012, 139:749-759.
19. Okada Y., Scott G., Ray M.K., Mishina Y., Zhang Y. Histone demethylase JHDM2A is critical for Tnp1 and Prm1 transcription and spermatogenesis. Nature 2007, 450:119-123.
20. Klose R.J., Yan Q., Tothova Z., Yamane K., Erdjument-Bromage H., Tempst P., Gilliland D.G., Zhang Y., Kaelin W.G. The retinoblastoma binding protein RBP2 is an H3K4 demethylase. Cell 2007, 128:889-900.
21. Iwamori N., Zhao M., Meistrich M.L., Matzuk M.M. The testis-enriched histone demethylase, KDM4D, regulates methylation of histone H3 lysine 9 during spermatogenesis in the mouse but is dispensable for fertility. Biol. Reprod. 2011, 84:1225-1234.
22. Catchpole S., Spencer-Dene B., Hall D., Santangelo S., Rosewell I., Guenatri M., Beatson R., Scibetta A.G., Burchell J.M., Taylor-Papadimitriou J. PLU-1/JARID1B/KDM5B is required for embryonic survival and contributes to cell proliferation in the mammary gland and in ER+ breast cancer cells. Int. J. Oncol. 2011, 38:1267-1277.
23. Rivlin N., Brosh R., Oren M., Rotter V. Mutations in the p53 tumor suppressor gene: important milestones at the various steps of tumorigenesis. Genes Cancer 2011, 2:466-474.
24. Riley T., Sontag E., Chen P., Levine A. Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell Biol. 2008, 9:402-412.
25. Pedersen M.T., Helin K. Histone demethylases in development and disease. Trends Cell Biol. 2010, 20:662-671.
26. Haferlach T., Kohlmann A., Wieczorek L., Basso G., Kronnie G.T., Bene M.C., De Vos J., Hernandez J.M., Hofmann W.K., Mills K.I., Gilkes A., Chiaretti S., Shurtleff S.A., Kipps T.J., Rassenti L.Z., Yeoh A.E., Papenhausen P.R., Liu W.M., Williams P.M., Foa R. Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. J. Clin. Oncol. 2010, 28:2529-2537.